The chief financial officer (CFO) of Sigma Pharmaceuticals, Mark Smith, has resigned from the drugs maker and distributor to pursue other interests. His resignation is effective immediately. KPMG partner Mark Watson will act as CFO until the Sigma board has appointed a replacement. Sigma has advised that the search for a replacement is underway.
Smith’s resignation comes a month after Sigma’s chief executive, Elmo de Alwis, quit the company, following its AU$390m loss in the 2010 fiscal year. Sigma shares dropped over 48% following that result. Following Smith’s resignation, the company’s share price has fallen 2.7%.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more